Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
11/2011
11/16/2011EP2386545A1 Heteroaryl ureas containing nitrogen hetero-atoms as P38 kinase inhibitors
11/16/2011EP2386540A1 Novel compounds, their preparation and use
11/16/2011EP2386311A1 Compositions for improving lipid metabolism
11/16/2011EP2386305A2 Selective Estrogen Receptor Modulator in Combination With Dehydroepiandrosterone (DHEA) or Analogues
11/16/2011EP2386304A2 Selective Estrogen Receptor Modulator in Combination With Dehydroepiandrosterone (DHEA) or Analogues
11/16/2011EP2385830A1 Treatment of diabetes in patients with inadequate glycemic control despite metformin therapy comprising a dpp-iv inhibitor
11/16/2011EP2142533B1 Imidazolidinone derivatives
11/16/2011EP1962826B1 Method for weight reduction
11/16/2011EP1948149B1 Formulation comprising metformin and vildagliptin
11/16/2011EP1924262B1 Methods and formulations for modulating lyn kinase activity and treating related disorders
11/16/2011EP1605963B1 Inhibitors of antigen presentation by mhc class ii molecules and methods of use thereof
11/16/2011EP1455588B1 Protein hydrolysate and plant sterol containing composition for improving serum lipid profile and preventing atherosclerosis
11/16/2011CN1757637B Method for purifying VE nicotinate raw material
11/16/2011CN102246030A A method of characterizing phytochemicals from trigonella foenum graceum
11/16/2011CN102245758A Materials and methds to enhance hematopoietic stem cells engraftment procedures
11/16/2011CN102245642A Conjugates of GLP-1 agonists and uses thereof
11/16/2011CN102245641A High affinity human antibodies to PCSK9
11/16/2011CN102245633A Novel insulin analogues
11/16/2011CN102245626A Mini-hepcidin peptides and methods of using thereof
11/16/2011CN102245608A Azolotriazinone melanin concentrating hormone receptor-1 antagonists
11/16/2011CN102245600A Pyrrolone melanin concentrating hormone receptor-1 antagonists
11/16/2011CN102245581A Tetrahydrotriazine compounds for treating diseases associated with AMPK activity
11/16/2011CN102245574A Compounds, pharmaceutical composition and methods for use in treating metabolic disorders
11/16/2011CN102245573A Heteroaryl derivatives as cftr modulators
11/16/2011CN102245187A Modulation of TOLL-like receptor 3 expression by antisense oligonucleotides
11/16/2011CN102245185A Combination of insulin with triazine derivatives and its use for treating diabetes
11/16/2011CN102245183A New compounds v
11/16/2011CN102245172A Oral formulations containing metformin and a-glycosidase inhibitor, and preparation method thereof
11/16/2011CN102242154A Liquid fermentation method for producing paecilomyces cicadae mycelia and application of culture product
11/16/2011CN102242079A Medium for producing Paecilomyces cicadae spore, culture method thereof, culture product thereof and application thereof
11/16/2011CN102242070A Method for artificially culturing paecilomyces cicadae and application of culturing product thereof
11/16/2011CN102242069A Paecilomycescicadae (Miq.)Samson and application thereof
11/16/2011CN102241785A Production technology of purslane polysaccharide
11/16/2011CN102241710A Salidroside analogues as well as preparation method and application thereof
11/16/2011CN102241680A Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
11/16/2011CN102241644A Alpha-azyl-3-aryl propionamido thiazole derivative, preparation method and purpose thereof
11/16/2011CN102241633A Linolenic acid-carnosine composite and preparation method thereof
11/16/2011CN102240405A Apolipoprotein A-I (ApoA-I) milano genetic medicine
11/16/2011CN102240397A Production of high mannose proteins in plant culture
11/16/2011CN102240371A Medicine for treating diabetes mellitus and preparation method thereof
11/16/2011CN102240358A Chinese medicinal blood fat removing and blood stasis eliminating mixture for treating hyperlipemia
11/16/2011CN102240343A Environment-friendly preparation method for high-ester catechin tea polyphenol
11/16/2011CN102240340A Method for processing prepared rehmannia root
11/16/2011CN102240332A Pharmaceutical composition and application thereof
11/16/2011CN102240312A Application of drugs by using inula britannica total flavone extract for reducing blood sugar
11/16/2011CN102240310A Blood-sugar-reducing composition and preparation method thereof
11/16/2011CN102240309A Application of valeriana jatamansi jones or extracts thereof in preparation of medicine for lowering fat and protecting liver
11/16/2011CN102240307A Preparation method of ginkgo leaf extract
11/16/2011CN102240306A Process for extracting proanthocyanidins from pine cone shells
11/16/2011CN102240302A Chinese medicine composition of super gene active peptide
11/16/2011CN102240299A Improved intravenously dripped multi-vitamin injection
11/16/2011CN102240293A Application of echinocystic acid in preparing medicament preventing and treating cardiovascular diseases
11/16/2011CN102240278A Methods, assays and compositions for treating retinol-related diseases
11/16/2011CN102240040A Oil body associated protein compositions and methods of use thereof for reducing the risk of cardiovascular disease
11/16/2011CN102240037A Amino acid and calcium composite powder
11/16/2011CN101891831B Method for preparing stable slow-digestion starch
11/16/2011CN101884665B Traditional Chinese medicine extract with alpha-glucuroide and xanthine oxidase inhibiting effect and preparation method and usage thereof
11/16/2011CN101869687B Medicament for treating fatty liver and alcohol liver, and reducing blood lipid and aminotransferase
11/16/2011CN101849932B Nutrient preparation of iron and zinc and preparation method thereof
11/16/2011CN101797312B Method for preparing Alisma extract capable of inhibiting alpha-glucuroide activity
11/16/2011CN101756962B Compound nateglinide valsatan medicinal composition
11/16/2011CN101659700B Short peptide
11/16/2011CN101654487B Preparation method for vanadium polysaccharide complex and application thereof
11/16/2011CN101627973B Calcium acetate tablet and preparation method thereof
11/16/2011CN101580755B Process for continuously extracting cordyceps militaris essential oil, cordycepin, cordycepic acid and cordyceps militaris polysaccharide from cordyceps militaris
11/16/2011CN101559081B Application of river clam extract in preparation of medicament for curing and preventing diabetes mellitus
11/16/2011CN101502559B Method for continuously extracting effective ingredients from Semen cassiae under high pressure
11/16/2011CN101484428B Alkyl-pyridazine derivatives as inhibitors of 11 beta hydroxysteroid dehydrogenase type 1(11b-HSD 1)
11/16/2011CN101448791B Fxr agonists
11/16/2011CN101411791B Method for preparing total flavones from leaf of Belamcanda rhizome and use
11/16/2011CN101365442B Use of benzo-fused heterocycle sulfamide derivatives for preparing medicine for the treatment of obesity
11/16/2011CN101365441B Use of benzo-fused heterocycle sulfamide derivatives for preparing medicine for lowering lipids and lowering blood glucose levels
11/16/2011CN101357144B Selaginella uncinata extraction, its preparation method and application
11/16/2011CN101326954B Method for producing feed containing Ganoderma lucidum acid from wheat straw transformed by Ganoderma lucidum and uses therefor
11/16/2011CN101302245B Melanin cortical hormone receptor tetrapeptide excitant, preparation and use thereof
11/16/2011CN101249129B Chinese medicine extract combination and medicine use thereof
11/16/2011CN101166529B Benzotriazole derivatives as cannabinoid receptor antagonists
11/16/2011CN101095942B Formulation of the Exendin injection medicine containing stabilizing agent
11/16/2011CN101010320B Aminotropane derivatives, preparation thereof and therapeutic use thereof
11/15/2011US8058426 Phosphorus-containing compounds and uses thereof
11/15/2011US8058425 Purine derivatives as kinase inhibitors
11/15/2011US8058400 Composition and method for modulating dendritic cell-t cell interaction
11/15/2011US8058282 2,4,8-trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds and compositions for use in therapy
11/15/2011US8058277 Substituted indoles
11/15/2011US8058267 Steroids as agonists for FXR
11/15/2011US8058245 Fused heterocycle derivative, medicinal composition containing the same, and medicinal use thereof
11/15/2011US8058233 Modification of feeding behavior using PYY and GLP-1
11/15/2011US8057825 Krill extracts for treatment of cardiovascular diseases
11/15/2011US8057789 Hematopoietic stem cell culture for use in treatment of blood disorders; regenerative medicine; tissue engineering
11/15/2011CA2624123C Glucagon-like peptide-1 secretagogue, glucagon-like peptide-1 secretagogue food or drink, inhibitor of postprandial rise in blood glucose, and inhibitory food or drink of postprandial rise in blood glucose
11/15/2011CA2488611C Compounds for modulating the activity of exchange proteins directly activated by camp (epacs)
11/15/2011CA2479126C Combination treatments for chemokine-mediated diseases
11/15/2011CA2469612C Treatment of statin side effects using uridine derivatives
11/15/2011CA2435067C Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
11/15/2011CA2429979C Treatment of statin side effects
11/10/2011WO2011140328A1 Saxagliptin intermediates, saxagliptin polymorphs, and processes for preparation thereof
11/10/2011WO2011140267A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of p38 multi-trna synthetase complex
11/10/2011WO2011140232A2 Desazadesferrothiocin and desazadesferrothiocin polyether analogues as metal chelation agents
11/10/2011WO2011140208A2 Methods and compositions for diagnosing and treating autoimmune disorders
11/10/2011WO2011140190A1 Tetrazolones as inhibitors of fatty acid synthase